Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivos Therapeutics

2.73
+0.0000
Post-market: 2.730.00000.00%18:29 EDT
Volume:73.02K
Turnover:198.37K
Market Cap:16.08M
PE:-1.23
High:2.82
Open:2.78
Low:2.64
Close:2.73
Loading ...
Aug 06, 2024

Correspondence

Form CORRESP - Correspondence
Jul 30, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Correspondence

Form CORRESP - Correspondence
Apr 22, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2023

Correspondence

Form CORRESP - Correspondence
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]